Following Wegovy’s arrival in Israel, the Health Ministry has today instructed pharmacists nationwide to cease selling Ozempic for weight loss, limiting its use to diabetes patients only. Those who have begun using Ozempic for weight loss are advised to gradually transition to Wegovy. The frenzy over Ozempic in Israel began a little over two years […]
Continue Reading
Nearly 500 million people around the world suffer from type-2 diabetes, caused mostly by poor diet, obesity, and lack of physical activity, and an estimated 200 million of them are dependent on insulin therapy for their health. In addition, there are about nine million people with type-1 diabetes because their pancreas doesn’t produce any insulin […]
Continue Reading
Patients with type-two diabetes are eager to find successful ways to reduce their blood sugar and control their metabolic disease. Now, UK researchers have found that 670 nanometers of red light on the backs of healthy individuals stimulated energy production within mitochondria – the tiny powerhouses within cells – leading to increased consumption of glucose. […]
Continue Reading
Type-1 diabetes (T1D), which used to be called “juvenile diabetes” but can be diagnosed in adults as well, is an autoimmune, chronic condition caused by the failure of the pancreas to produce any or enough insulin to let glucose enter the cells properly and produce energy. Different factors including genetics can cause it, and scientists […]
Continue Reading
It has been known for decades that diabetics and pre-diabetics with high levels of blood sugar (hyperglycemia) are at a substantially increased risk of developing severe lung disease if they become infected with viruses such as influenza, as well as with bacteria and fungi. This mysterious phenomenon became even more pressing when the COVID-19 pandemic […]
Continue Reading
